Market data
Medical Conditions Disorders
Explore verified medical conditions disorders statistics and market research reports with sourced data and trend analysis.
Latest update:
Elif Demirci
Men Breast Cancer Statistics
Men’s breast cancer is rare, but the statistics are not standing still, with about 2,800 new cases expected in the US in 2025 and roughly 500 deaths projected. Read to see how age and risk factors shift what “rare” really means and why early warning signs deserve attention sooner than many people think.
Ischemic Stroke Statistics
With 4.39 million ischemic stroke deaths and 5.31 million DALYs lost worldwide in 2019, the page turns the burden into clear, action focused risk and treatment signals. It weighs why blocked arteries account for about 85% of cases and how factors like hypertension, atrial fibrillation, and diabetes shape risk, then contrasts that preventable trajectory with what moves outcomes when time matters, including thrombectomy results and early antiplatelet gains.
Asd Statistics
Find out how Asd’s most recent metrics are reshaping the picture, with 2026 figures showing a sharper shift than last year’s trend. If you think you know what the data says, these updated numbers will likely make you reconsider where the pressure points actually are.
Shaken Baby Syndrome Statistics
The latest statistics make one uncomfortable point clear: shaken baby syndrome can be mistaken for ordinary injury, yet outcomes are devastating and time to recognize warning signs is brutally short. This page brings the most current figures side by side so you can see how often tragedy follows missed cues.
Amyloidosis Statistics
From a 6.0 point mean mNIS+7 separation at 18 months with vutrisiran and tafamidis reducing cardiovascular hospitalization in ATTR-ACT to real world patterns where over 50% of AL patients carry cardiac diagnosis codes within a year, this page puts efficacy, safety, and delayed diagnosis into one striking, decision ready snapshot. It also tracks how claims data finds 1.5 to 2.0 times more hospitalizations and budgets can exceed $100 million annually, so you can see where amyloidosis outcomes and costs truly diverge.
Dyslexia Statistics
Dyslexia affects about 1 in 5 people, yet most adults still don’t recognize what that means in everyday learning and work. Read the page to see the most current statistics and the gap between how dyslexia is measured and how it is understood.
Fibroids Statistics
Fibroids are anything but a niche health issue, with 1 in 5 people affected worldwide, and the need for careful management becomes clearer when you see how often heavy bleeding drives diagnosis. Find out how symptoms and treatment patterns vary enough to change what “typical” looks like, and why the latest statistics matter for decisions made today.
Miscarriages Statistics
Miscarriage is estimated to occur in about 20% of clinically recognized pregnancies, yet the risk can jump from roughly 8% when a fetal heartbeat is present after 6 weeks to far higher rates by age 40, reaching about 25%–50%, with recurrent loss affecting about 2% of women. This page connects those timing and age patterns to ACOG guidance on uterine aspiration, plus the key factors and costs that shape real-world care decisions and follow-up.
Cold Sore Statistics
Cold sores are getting more than just attention. The latest figures for 2025 show how quickly new outbreaks surface and how often they return, turning a once occasional blister into a pattern.
Reactive Attachment Disorder Statistics
Reactive Attachment Disorder statistics can look small and rare on paper, yet the lived impact is often concentrated and urgent once risk factors stack up. See the 2026 figures alongside the most current benchmarks to understand where early attachment breakdowns are most likely to show up and why those differences matter for prevention.
Cervical Cancer Statistics
Cervical cancer incidence and survival trends have shifted enough that the latest figures for 2025 are worth a closer look, especially for people who think prevention is only about screening. Get the key statistics that explain where risk is rising or falling and what outcomes mean for timely action.
Diabetic Statistics
Type 1 diabetes makes up just 5 to 10% of all cases yet the outcomes it influences are shaped by treatment effects like a 10 mmHg systolic blood pressure drop linked to 13% fewer major cardiovascular events and each 1% HbA1c reduction tied to major drops in endpoints including a 37% reduction in microvascular complications. The page also brings the burden into sharp focus with diabetes deaths at 24.3 per 100,000 in 2021 and diabetes-attributable health spending in Europe at $328.1 billion in 2021 alongside trial results where newer agents like semaglutide and empagliflozin deliver measurable cardiovascular gains.
Ewing Sarcoma Statistics
See how Ewing sarcoma represents about 0.9% of all malignant bone tumors and about 5% of childhood cancer diagnoses, yet can split outcomes sharply with 65% event free survival at 5 years for localized disease compared with far lower results after metastasis. Track what happens after diagnosis and beyond, from 25% recurrence in localized cases and a 16% overall response rate for dinutuximab in relapsed or refractory disease to the frequent realities of care like dose modifications in 25% of patients and hematologic toxicity in 60% of those on intensive regimens.
Mesothelioma Statistics
Mesothelioma statistics are changing in meaningful ways, with the latest estimates pointing to 2,700 to 3,000 new diagnoses in the US each year. Because exposure timelines can span decades, these up to date counts help you connect current burden to past asbestos use and understand who is most at risk now.
Birth Control Infertility Statistics
If you have ever wondered how quickly fertility can return after contraception, the timing is often more reassuring than expected, with 87% of women resuming normal ovulation markers within 6 months after stopping DMPA and many reaching pregnancy within 12 months. But infertility is still widespread, affecting about 48 million couples globally, so this page connects the return to ovulation timelines with the bigger picture of why contraception discontinuation and fertility hurdles can look so different from one person to the next.
Cancer Death Statistics
For 2026, Cancer Death statistics show a grim shift in how many people are expected to be lost, and it is not where most families would guess. Get the key numbers behind the trend and the risk patterns that shape what happens next.
Melanoma Skin Cancer Statistics
With melanoma still responsible for about 3.3% of US cancer deaths in 2024, this page connects the numbers that matter to outcomes including why localized melanoma has a 99% 5 year relative survival versus 27% when it has spread. You will also see how rising incidence and smarter detection tools like dermoscopy, targeted screening, and teledermatology are changing what gets diagnosed and when, alongside trial results and real world testing rates shaping today’s treatment choices.
Stomach Cancer Statistics
More than half of stomach cancer cases are diagnosed at a late stage, but the survival gap is even wider than most people expect, making the timing matter as much as the treatment. Get the latest 2026 figures on how often this cancer is found and what that means for outcomes, so you can spot the risk patterns before they become a statistic.
Antimicrobial Resistance Statistics
Antimicrobial resistance already drives 35.7 million AMR-associated DALYs and 1.27 million deaths in 2019, but the page also shows where action can bend the curve, including hospital antibiotic stewardship cutting antibiotic use by about 13% and rapid tests shortening time to optimal therapy. It then connects those outcome shifts to the money and momentum behind testing and prevention, from rising diagnostics markets toward 2030 to the economic hit that could cut global GDP by 3.8% by 2050 if policy stalls.
Global Autism Statistics
Autism looks similar on paper worldwide, yet the figures swing dramatically from about 1% global prevalence to higher identification rates in specific settings and reveal why access and early support still vary so much. Find 2025 ready takeaways on costs, comorbidities, and what helps, alongside service access gaps such as the 56% of U.S. children ages 3 to 17 with autism who lacked enough health insurance for needed services.